BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Apr 18, 2023
Deals

April 17 Quick Takes: J&J, Pipeline in deal for remyelination therapy for MS

Plus: FDA approves Gamida Cell’s omidubicel and updates from Vaxcyte, Otsuka, Lundbeck, Innoviva and more  
BioCentury | Feb 26, 2019
Distillery Therapeutics

Cancer

BioCentury | Sep 19, 2018
Distillery Techniques

Chemistry

BioCentury | Oct 19, 2015
Clinical News

MGCD516: Interim Phase I data

BioCentury | Dec 11, 2014
Distillery Therapeutics

Indication: Cancer

BioCentury | Sep 15, 2014
Clinical News

MGCD516: Phase I started

BioCentury | May 16, 2013
Distillery Therapeutics

Indication: Cancer

BioCentury | Apr 11, 2013
Cover Story

RET, set, go

BioCentury | Mar 11, 2013
Emerging Company Profile

Blackfield: Mining cancer genomes

Blackfield offering cancer genomics-based drug discovery services
BioCentury | Mar 1, 2012
Cover Story

REThinking lung cancer

Items per page:
1 - 10 of 12
Help Center
Username
Request Training
Ask a Question
Request a Demo